Search results
Sep 5, 2024 · Our broad portfolio of approximately 280+ generic and specialty pharmaceuticals is the foundation from which we make healthy possible. And we expanded our portfolios to institutions, in biosimilars and across select international markets.
- Careers
We have received reports of incidents in which people are...
- Contact
Amneal and Impax Products (877) 835-5472, option 3....
- Generic Products
We distribute our products through deeply-held relationships...
- Our Story
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered...
- Investor Relations
Amneal is a global, diversified pharmaceutical company that...
- Research & Development
2002: Amneal Founded 2005: Oral Solids 2008: Oral Liquids...
- News
Selecting a year value will change the news content. Select...
- Customer Login
Welcome to the Amneal portal. We’ve designed this portal as...
- Quality
Integrity – We deliver quality pharmaceuticals that are safe...
- Drug Safety
We are focused on the safety and well-being of patients. To...
- Careers
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey. [2]
In the US, our portfolio of more than 280 medicines provides patients with more affordable access to quality medicines. Our growing Specialty portfolio meets important medical needs in neurology, endocrinology and other therapeutic categories.
People also ask
Who is Amneal Pharmaceuticals?
How many followers does Amneal Pharmaceuticals have?
What does Amneal do?
Does Amneal make healthy possible?
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global pharmaceuticals company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 generic and specialty pharmaceuticals, primarily within the United States.
Find the latest Amneal Pharmaceuticals, Inc. (AMRX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Our family delivers for yours...
Aug 7, 2024 · BRIDGEWATER, N.J.-- (BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved CREXONT ® (carbidopa and levodopa) extended-release capsules for the treatment of Parkinson’s disease (PD).
